Holen Sie sich die Stockscreener-App
213.81
0.00%
0.010
Handel nachbörslich:
214.02
0.21
+0.10%
Schlusskurs vom Vortag:
$213.80
Offen:
$214.7
24-Stunden-Volumen:
1.61M
Relative Volume:
1.02
Marktkapitalisierung:
$9.09B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.46%
1M Leistung:
+15.01%
6M Leistung:
+25.70%
1J Leistung:
+52.33%
1-Tages-Spanne:
$211.49
$214.94
1-Wochen-Bereich:
$206.01
$215.31
52-Wochen-Spanne:
$138.78
$217.12
Ishares Biotechnology Etf Stock (IBB) Company Profile
Firmenname
Ishares Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare IBB vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
213.81 | 9.09B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
380.93 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
773.17 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
777.13 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
299.85 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
717.67 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Aktie (IBB) Neueste Nachrichten
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? - The Motley Fool
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? - The Motley Fool
Biotech Is Booming, But These 2 Stocks Missed the MemoModerna (NASDAQ:MRNA), iShares Biotechnology ETF - Benzinga
Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In FocusMerck & Co (NYSE:MRK) - Benzinga
Ishares Biotech ETF up 3.2%, State Street Spd - Moomoo
Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For - Sahm
iShares Biotechnology ETF (NASDAQ: IBB) Share Price, IBB Stock News, IBB Share Price & Updates - Kalkine
Wagner Wealth Management, Corp's iShares Biotechnology ETF(IBB) Holding History - GuruFocus
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? - The Motley Fool
Moderna Advances Ebola Vaccine Into Human Testing - Sahm
Arrivent Biopharma Inc (AVBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iShares Biotechnology ETF Shs Cert Deposito Arg Repr 0.037037037 Sh Revenue Breakdown – BCBA:IBB - TradingView
Biomea Fusion Inc (BMEA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Neurogene Inc (NGNE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It - 24/7 Wall St.
Sutro Biopharma Inc (STRO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oruka Therapeutics Inc (ORKA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anavex Life Sciences Corp (AVXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alumis Inc (ALMS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iShares Biotechnology ETF Shs Cert Deposito Arg Repr 0.037037037 Sh Revenue Breakdown – BCBA:IBB.CI - TradingView
Sana Biotechnology Inc (SANA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Altimmune Inc (ALT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? - The Motley Fool
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB? - The Motley Fool
iShares Biotechnology ETF (rIBB) Price Prediction - Bitget
Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026? - The Motley Fool
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT? - The Motley Fool
Buying Biotech's Policy Discount With XBI And IBB: Most 'Feared' Nation Policy, Less-Than-Feared Damage - Seeking Alpha
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy? - The Globe and Mail
Understanding the Shape of the iShares Biotechnology ETF Portfolio - sekbernews.id
iShares Biotechnology ETF’s Concentrated Portfolio Poses Unique Risks for Sector InvestorsOperating Income Trends - Vinanet
IBB ETF Holds Fewer Bets Than You Think - Trefis
$188.977 | iShares Biotechnology ETF (IBB) Stock Price Today - Binance
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - AOL.com
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - The Motley Fool
Healthcare ETFs Face-Off: Stability vs. Biotech Growth, Which Strategy Wins? - finance.biggo.com
5 Best Biotech ETFs for 2026 and How to Invest - The Motley Fool
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy? - The Motley Fool
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.0238 - MSN
VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal? - TradingView
Cramer’s mad dash: iShares Biotechnology ETF - MSN
iShares Biotechnology ETF(IBB) Stock Options Chain | Quotes & News - Moomoo
Cramer’s Mad Dash: iShares Biotechnology ETF - CNBC
Finanzdaten der Ishares Biotechnology Etf-Aktie (IBB)
Es liegen keine Finanzdaten für Ishares Biotechnology Etf (IBB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):